Your session is about to expire
← Back to Search
Pivotal Response Treatment for Autism (PRT-I Trial)
PRT-I Trial Summary
This trial is investigating whether neuroimaging can predict which children with ASD will respond best to an evidence-based behavior intervention.
PRT-I Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRT-I Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRT-I Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with Autism Spectrum Disorder.I am between 2 and 4 years old.My child can follow the testing procedures well enough for accurate results.My mental health medication or treatment has been stable for at least a month.I have been on a stable treatment plan for my condition, including therapy and school placement, for at least 1 month.I receive 60 minutes or less of speech therapy weekly.My child is exposed to enough English for tests in English to measure their progress accurately.I have a genetic condition like Fragile X.I have a medical condition that is not under control, like seizures.I am getting over 15 hours of ABA therapy at home weekly.I have a parent available to join the training sessions with me.
- Group 1: Pivotal Response Treatment Program (PRT-P)
- Group 2: Delayed Treatment Group (DTG)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are applicants below the age of fifty-five eligible for this study?
"The target demographic for this clinical trial are individuals aged between 2 and 4 years old."
Am I able to become a participant in this research?
"This trial is enrolling 36 infants and toddlers aged 2 to 4 years old with autism spectrum disorder. The following conditions should be satisfied for successful enrollment: stable psychotropic or biomedical treatments, no severe language impairment (1 SD below mean at ages 2-3; 2 SDs below the mean at age 4), persistent engagement in ABA/Floortime therapy over a month period prior to baseline measurements, weekly speech therapy of less than 1 hour duration, and active parental involvement throughout the testing procedures."
Is there still availability for participants in this experiment?
"Affirmative. According to information presented on clinicaltrials.gov, this medical experiment is still accepting participants and was initially posted on December 7th 2018; the most recent update occurred February 15th 2022. 36 individuals are required for participation across 1 site."
Share this study with friends
Copy Link
Messenger